Skip to content

NEOGENOMICS INC

Public company
Headquarters
FORT MYERS, Florida
Ticker
NEO
CIK
0001077183

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

4
2 appointments, 1 departure

Last event

Oct 5, 2026
Executive appointmentCEO appointed: Warren Stone

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
CEOWarren StoneOct 5, 2026Appointed
Executive ChairmanTony ZookOct 5, 2026Role change
ChairLynn TetraultOct 5, 2026Departed
Lead Independent DirectorMichael KellyOct 5, 2026Appointed

  1. Executive appointment

    CEO appointed: Warren Stone

    Warren Stone was named Chief Executive Officer of NEOGENOMICS INC, effective January 4, 2027. Warren Stone succeeds Tony Zook. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Executive Officer

    Source: SEC 8-K, filed Oct 5, 2026

  2. Role change

    Executive Chairman role change: Tony Zook

    Tony Zook moved to Executive Chairman at NEOGENOMICS INC, effective January 4, 2027. The company reported the change in an 8-K that cites Item 5.02.

    Role: Executive Chairman

    Source: SEC 8-K, filed Oct 5, 2026

  3. Executive departure

    Chair departs: Lynn Tetrault

    Lynn Tetrault, Chair of NEOGENOMICS INC, departs the role, effective January 4, 2027. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chair

    Source: SEC 8-K, filed Oct 5, 2026

  4. Executive appointment

    Lead Independent Director appointed: Michael Kelly

    Michael Kelly was named Lead Independent Director of NEOGENOMICS INC, effective January 4, 2027. The company reported the change in an 8-K that cites Item 5.02.

    Role: Lead Independent Director

    Source: SEC 8-K, filed Oct 5, 2026

Last verified Nov 8, 2026